I am honored to become a member of the ECPC Scientific Committee. For several years I have been collaborating with ECPC in various projects. In fact, I believe that collaboration with patient associations is essential to ensure a more rapid transfer of new knowledge into clinical practice. The collaboration with ECPC has always been very fruitful for the dedication of the members and staff of the association and for their interest in the advancement of cancer research.
I received my medical degree in 1988 and my specialty in Oncology on 1991. After a period of study and work at the National Cancer Institute (NCI) in the USA, I returned to Italy in 1993 at the Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale” where I started a translational research program. I am currently Director of the Cell Biology and Biotherapy Unit and of the Translational Research Department. My research group is involved in both pre-clinical and clinical studies, with particular regard to the identification of biomarkers associated with sensitivity/resistance to target-based agents in clinical development. I am also involved in clinical diagnostics and in the organization of national and international external quality assessment (EQA) schemes in molecular pathology. I am President of the International Quality Network for Pathology (IQN Path) and President of the Italian Cancer Society (SIC). I co-authored more than 300 publications in peer-reviewed journals.
Cancer is the second leading cause of death in the world. Since I was a teenager, I have seen the devastating impact of the disease on patients and their families. Since then, I have cultivated the aspiration to help find new therapies to treat cancer. For this reason, I became a medical oncologists and I have been involved in cancer research since I was a medical student.
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.
Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages